E-mail: gzliang@cqu.edu.cn    Tel: (86)2365102507

List of peptide properties
DFBP ID - DFBPACEI0288(ACE-inhibitory peptide)
DFBP ID DFBPACEI0288
Peptide sequence ALPMHIR
Type Native peptide
Peptide/Function name ACE-inhibitory peptide
Function-activity relationship
Main bioactivity ACE-inhibitory activity
Otheir bioactivity Antioxidative activity [D1], DPP IV-inhibitory activity [D2], Multifunctional activity [D3]
Calculated physicochemical properties
Three-letter amino acid Ala-Leu-Pro-Met-His-Ile-Arg
Single-letter amino acid ALPMHIR
Peptide length 7
Peptide mass
Experimental mass Theoretical mass
836.5 Da 837.04 Da c
Net charge 0.00 c
Isoelectric point (pI) 11.04 c
IC50 N.D
pIC50 N.D
GRAVY 0.3857 c
Hydrophilic residue ratio 71.43% c
Peptide calculator
To calculate the physicochemical properties of bioactive peptide.
Peptide source & Food-borne protein(s) search
Classification Animal
Organism/Source Ovine milk protein
Precursor protein β-Lactoglobulin
Residue position f(142-148)
Precursor protein(s) search
Link-research
Link 1: DFBPACEI0028----Bovine whey protein----β-Lactoglobulin
Biological/Functional activity & target protein
ACE-inhibitory activity

The peptide exhibited potent Angiotensin-Converting Enzyme (ACE) (EC 3.4.15.1) inhibitory activity with an ACE inhibition rate of
62.6 ± 0.6 %.

Specific target protein(s) Specific Target Protein(s):
Angiotensin-converting enzyme
Taste properties & Structure
Bitterness
Literature report N.D
Bitter prediction tools Bitter taste prediction
SMILES N[C@@]([H])(C)C(=O)N[C@@]([H])(CC(C)C)C(=O)N1[C@@]([H])(CCC1)C(=O)N[C@@]([H])(CCSC)C(=O)N[C@@]([H])(CC1=CN=C-N1)C(=O)N[C@@]([H])([C@]([H])(CC)C)C(=O)N[C@@]([H])(CCCNC(=N)N)C(=O)O
Preparation method
Mode of preparation Enzymatic hydrolysis
Enzyme(s)/starter culture

Ovine milk was hydrolyzed with trypsin (EC 3.4.21.4 type XIII from bovine pancreas; Sigma Chemical Company, St. Louis, MO, USA).

Stability & Cytotoxicity
Peptide stability
Literature report: N.D
EHP-Tool: Enzymatic Hydrolysis Prediction Tool (EHP-Tool)
Peptide cytotoxicity
Literature report: No measured
Prediction: ToxinPred
Additional information
Additional information

Whey protein/hydrolysates may find application as nutraceuticals in various "physiologically functional foods".

Database cross-references
DFBP
[D1] DFBPANOX0698
[D2] DFBPDPIV0215
[D3] DFBPMUFU0016
BIOPEP-UWM [D4] 3261
APD [D5] -
BioPepDB [D6] -
MBPDB [D7] -
Reference(s)
Primary literature Chobert, J.-M., El-Zahar, K., Sitohy, M., Dalgalarrondo, M., Métro, F., Choiset, Y., et al. Angiotensin I-converting-enzyme (ACE)-inhibitory activity of tryptic peptides of ovine β-lactoglobulin and of milk yoghurts obtained by using different starters. Le Lait. 2005, 85, 141-52.
Other literature(s)

[1] Park Y W. Bioactive Components in Milk and Dairy Products[M]. 2009.
[2] Mullally M M, Meisel H, Fitzgerald R J. Identification of a novel angiotensin-I-converting enzyme inhibitory peptide corresponding to a tryptic fragment of bovine beta-lactoglobulin[J]. Febs Letters, 1997, 402(2–3):99-101.
[3] Fitzgerald R J, Meisel H. Lactokinins: Whey protein‐derived ACE inhibitory peptides[J]. Molecular Nutrition (&) Food Research, 1999, 43(3):165.
[4] I.M.P.L.V.O. Ferreira, Pinho O, Mota M V, et al. Preparation of ingredients containing an ACE-inhibitory peptide by tryptic hydrolysis of whey protein concentrates[J]. International Dairy Journal, 2007, 17(5):481-487.

PubDate 2005
Copyright © 2020. Record / license number: Chongqing ICP No. 2000214